摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(1,2-diamino-1-methylethyl)-1-cyclopropanecarboxylic acid tert-butyl ester | 915794-99-9

中文名称
——
中文别名
——
英文名称
1-(1,2-diamino-1-methylethyl)-1-cyclopropanecarboxylic acid tert-butyl ester
英文别名
tert-butyl 1-(1,2-diamino-1-methylethyl)-1-cyclopropane carboxylate;Tert-butyl 1-(1,2-diamino-1-methylethyl)-1-cyclopropanecarboxylate;tert-butyl 1-(1,2-diaminopropan-2-yl)cyclopropane-1-carboxylate
1-(1,2-diamino-1-methylethyl)-1-cyclopropanecarboxylic acid tert-butyl ester化学式
CAS
915794-99-9
化学式
C11H22N2O2
mdl
——
分子量
214.308
InChiKey
VKAQSORPKHXFEL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.3
  • 重原子数:
    15
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.91
  • 拓扑面积:
    78.3
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • TRI-, TETRA-SUBSTITUTED-3-AMINOPYRROLIDINE DERIVATIVE
    申请人:TAKAHASHI Hisashi
    公开号:US20090253726A1
    公开(公告)日:2009-10-08
    A quinolone synthetic antibacterial agent and a therapeutic agent for an infection which exhibit broad spectrum and strong antibacterial activity for both Gram positive and Gram negative bacteria, and which are also highly safe are provided. The compound provided is represented by formula (I):
    提供了一种喹诺酮合成抗菌剂和治疗感染的药物,具有广谱和强大的抗菌活性,对革兰氏阳性和革兰氏阴性细菌均有作用,并且非常安全。所提供的化合物由式(I)表示。
  • METHOD FOR PRODUCING ASYMMETRIC TETRASUBSTITUTED CARBON ATOM-CONTAINING COMPOUND
    申请人:Tani Yuichiro
    公开号:US20090054648A1
    公开(公告)日:2009-02-26
    The invention provides an industrial method for producing a spiroaminopyrrolidone derivative, which is an intermediate for producing a quinolone antibacterial agent. The invention provides a method for producing a compound represented by formula (2): (wherein n is an integer of 2 to 5; R 1 represents a (substituted) alkyl group or a (substituted) aryl group; and R 2 represents a (substituted) alkoxycarbonyl group, a (substituted) aralkyloxycarbonyl group, a (substituted) aliphatic acyl group, or a (substituted) aromatic acyl group), which includes treating a compound represented by formula (1): (wherein n, R 1 , and R 2 are the same as defined above; and R 3 represents a hydrogen atom, a (substituted) alkyl group, or a (substituted) aralkyl group) under a hydrogen gas atmosphere in the presence of a metallic catalyst.
    本发明提供了一种工业方法,用于生产螺环吡咯烷衍生物,该衍生物是生产喹诺酮类抗菌剂的中间体。本发明提供了一种生产由式(2)表示的化合物的方法:(其中n是2至5的整数;R1表示(取代)烷基或(取代)芳基;R2表示(取代)烷氧羰基,(取代)芳基烷氧羰基,(取代)脂肪酰基或(取代)芳香酰基),其包括在属催化剂存在下,在氢气气氛下处理由式(1)表示的化合物:(其中n,R1和R2如上定义;R3表示氢原子,(取代)烷基或(取代)芳基烷基)。
  • Method for Production of Quinolone-Containing Lyophilized Preparation
    申请人:Nishimoto Norihiro
    公开号:US20080300403A1
    公开(公告)日:2008-12-04
    The present invention is directed to a lyophilized preparation which contains a synthetic quinolone antibacterial compound and, as a solo additive, a pH-adjusting agent, and which exhibits an excellent reconstituting property. The invention provides a method for producing a lyophilized preparation containing a synthetic quinolone antibacterial compound as an active ingredient, characterized by including, sequentially, cooling an aqueous solution containing a synthetic quinolone antibacterial compound and a pH-adjusting agent to yield a frozen product, elevating the temperature of the frozen product, and re-cooling the resultant to prepare the lyophilized preparation.
    本发明涉及一种冻干制剂,其包含合成喹诺酮类抗菌化合物和一个pH调节剂作为单一添加剂,并表现出优异的重构性能。本发明提供了一种制备含有合成喹诺酮类抗菌化合物作为活性成分的冻干制剂的方法,其特征在于依次包括将含有合成喹诺酮类抗菌化合物和pH调节剂的溶液冷却以产生冻结产物,提高冻结产物的温度,然后再次冷却以制备冻干制剂。
  • Hydrate for medical purposes
    申请人:Daiichi Sankyo Company, Limited
    公开号:US08003666B2
    公开(公告)日:2011-08-23
    The present invention relates to [7-[(7S)-7-amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-8-methoxy-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hemihydrate. This hemihydrate is stable and easy to prepare, and has excellent properties for a pharmaceutical bulk powder.
    本发明涉及[7-[(7S)-7-基-7-甲基-5-氮杂螺[2.4]庚烷-5-基]-6--1-[(1R,2S)-2-环丙基]-8-甲氧基-1,4-二氢-4-氧喹啉-3-羧酸合物。该半合物稳定易于制备,具有优异的药用原料粉末性能。
  • TRI- OR TETRA-SUBSTITUTED-3-AMINOPYRROLIDINE DERIVATIVES
    申请人:Daiichi Sankyo Company, Limited
    公开号:EP1882689A1
    公开(公告)日:2008-01-30
    A quinolone synthetic antibacterial agent and a therapeutic agent for an infection which exhibit broad spectrum and strong antibacterial activity for both Gram positive and Gram negative bacteria, and which are also highly safe are provided. The compound provided is represented by following formula (I): wherein R1 and R2 represent hydrogen atom, or the like; R3 represents an alkyl group containing 1 to 6 carbon atoms, or the like; R4 and R5 independently represents hydrogen atom, an alkyl group containing 1 to 6 carbon atoms, or the like, with the proviso that R4 and R5 do not simultaneously represent hydrogen atom; or the substituents R4 and R5 together represent (a) a 3- to 6-membered cyclic structure including the carbon atom shared by R4 and R5 to form a spirocyclic structure with the pyrrolidine ring; R6 and R7 independently represents hydrogen atom, an alkyl group containing 1 to 6 carbon atoms, or the like; R8 represents a halogen-substituted alkyl group containing 1 to 6 carbon atoms, or the like; X1 represents hydrogen atom or a halogen atom; A represents nitrogen atom or a moiety represented by formula (II):
    本发明提供了一种喹诺酮类合成抗菌剂和一种治疗感染的药物,对革兰氏阳性菌和革兰氏阴性菌均具有广谱、强效的抗菌活性,而且安全性高。所提供的化合物由下式(I)表示: 其中 R1 和 R2 代表氢原子或类似物;R3 代表含有 1 至 6 个碳原子的烷基或类似物;R4 和 R5 独立地代表氢原子、含有 1 至 6 个碳原子的烷基或类似物,但 R4 和 R5 不同时代表氢原子;或取代基 R4 和 R5 共同代表 (a) 3 至 6 元环状结构,包括 R4 和 R5 共用的碳原子,与吡咯烷环形成螺环结构;R6 和 R7 独立代表氢原子、含 1 至 6 个碳原子的烷基或类似物;R8 代表含 1 至 6 个碳原子的卤素取代烷基或类似物;X1 代表氢原子或卤素原子;A 代表氮原子或式 (II) 所代表的分子:
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸